Technical Data
N5310-01
(S)-(-)-Norverapamil ((aS)-a-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]amino]propyl]-3,4-dimethoxy-a-(1-methylethyl)-benzeneacetonitrile, (S)-Norverapamil)
1mg
|
Technical Data |
|
N5310-01 |
(S)-(-)-Norverapamil ((aS)-a-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]amino]propyl]-3,4-dimethoxy-a-(1-methylethyl)-benzeneacetonitrile, (S)-Norverapamil) |
1mg |
| Biochemicals | Storage: -20°CShipping: RT |
|
The chiral metabolite of Verapamil. Source:Synthetic Melting Point: As reported Solubility: As reported Stability: As reported Atmosphere: As reported Method for Determining Identity: Proton NMR (D2O) Spectroscopic and Mass Spectrometric Analysis TLC Conditions: SiO2; Dichloromethane: Methanol; 9:1; Visualized with UV and AMCS; Single spot; Rf=0.50 chloride content: As reported Storage and Stability: May be stored at RT for short-term only. Long-term storage is recommended at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. Toxicity and Hazards: All products should be handled by qualified personnel only, trained in laboratory procedures. Molecular Formula: C26H36N2O4 HCl Molecular Weight: 477.04 |
Source: Synthetic Purity: ~90% Form: Supplied as a white solid. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
|
||